AG
QTTB icon

Aperio Group’s Q32 Bio QTTB Stock Holding History

Aperio Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-95
Closed -$34K – 2786
2019
Q2 		$34K Buy
+95
New +$37.3K ﹤0.01% 2608

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aperio Group's QTTB Position: Q3 2019 in Review

Aperio Group sold out of Q32 Bio (QTTB) in Q3 2019, closing a stake of 95 shares — an estimated $34K sold.

Aperio Group first reported a position in QTTB in Q2 2019 and held it in 1 quarter. The position peaked at $34K in Q2 2019. 80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

  • Aperio Group reported no remaining Q32 Bio position as of Q3 2019 after selling out during the quarter.
  • Aperio Group sold 95 Q32 Bio shares in Q3 2019, an estimated $34K.
  • Aperio Group first reported a position in Q32 Bio in Q2 2019 and held it in 1 quarter.
  • Aperio Group's Q32 Bio position peaked at $34K in Q2 2019.
  • 80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.